Kadimastem (XTAE:KDST) Ending Cash Position : ₪4.16 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Kadimastem Ending Cash Position?

Kadimastem's Ending Cash Position for the quarter that ended in Dec. 2023 was ₪4.16 Mil.

Kadimastem's quarterly Ending Cash Position declined from Dec. 2022 (₪6.39 Mil) to Jun. 2023 (₪4.19 Mil) and declined from Jun. 2023 (₪4.19 Mil) to Dec. 2023 (₪4.16 Mil).

Kadimastem's annual Ending Cash Position declined from Dec. 2021 (₪23.29 Mil) to Dec. 2022 (₪6.39 Mil) and declined from Dec. 2022 (₪6.39 Mil) to Dec. 2023 (₪4.16 Mil).

Kadimastem Ending Cash Position Historical Data

The historical data trend for Kadimastem's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kadimastem Ending Cash Position Chart

Kadimastem Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

0.05

5.43

23.29

6.39

4.16

Kadimastem Semi-Annual Data
	Dec13	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Ending Cash Position	Get a 7-Day Free Trial														23.29	15.16	6.39	4.19	4.16

Kadimastem Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Kadimastem's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6.392	+	-2.237
	=	4.16

Kadimastem's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4.19	+	-0.035
	=	4.16

Kadimastem Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Kadimastem's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Kadimastem (XTAE:KDST) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadimastem Ltd (XTAE:KDST) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

KMSTF:USA

Address

Pinchas Sapir 7, Weizmann Science Park, Nes-Ziona, ISR

Website

http://www.kadimastem.com

Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.

Kadimastem (XTAE:KDST) Headlines

No Headlines